Development and Progression of Renal Insufficiency With and Without Albuminuria in Adults With Type 1 Diabetes in the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications Study
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: This multicenter study examined the impact of albumin excretion rate (AER) on the course of estimated glomerular filtration rate (eGFR) and the incidence of sustained eGFR <60 ml/min/1.73 m2 in type 1 diabetes up to year 14 of the Epidemiology of Diabetes Interventions and Complications (EDIC) study (mean duration of 19 years in the Diabetes Control and Complications Trial [DCCT]/EDIC). RESEARCH DESIGN AND METHODS: Urinary albumin measurements from 4-h urine collections were obtained from participants annually during the DCCT and every other year during the EDIC study, and serum creatinine was measured annually in both the DCCT and EDIC study. GFR was estimated from serum creatinine using the abbreviated Modification of Diet in Renal Disease equation. RESULTS: A total of 89 of 1,439 subjects developed an eGFR <60 ml/min/1.73 m2 (stage 3 chronic kidney disease on two or more successive occasions (sustained) during the DCCT/EDIC study (cumulative incidence 11.4%). Of these, 20 (24%) had AER <30 mg/24 h at all prior evaluations, 14 (16%) had developed microalbuminuria (AER 30–300 mg/24 h) before they reached stage 3 chronic kidney disease, and 54 (61%) had macroalbuminuria (AER >300 mg/24 h) before they reached stage 3 chronic kidney disease. Macroalbuminuria is associated with a markedly increased rate of fall in eGFR (5.7%/year vs. 1.2%/year with AER <30 mg/24 h, P < 0.0001) and risk of eGFR <60 ml/min/1.73 m2 (adjusted hazard ratio 15.3, P < 0.0001), whereas microalbuminuria had weaker and less consistent effects on eGFR. CONCLUSIONS: Macroalbuminuria was a strong predictor of eGFR loss and risk of developing sustained eGFR <60 ml/min/1.73 m2. However, screening with AER alone would have missed 24% of cases of sustained impaired eGFR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Reduced eGFR without albuminuria has been frequently reported in type 1 and type 2 diabetes and is becoming more common over time as the prevalence of diabetes increases in the U.S. (2,3,16,(19)(20)(21).”
From 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [19]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Density Estimation for Statistics and Data Analysis
Silverman, B. W. (2018) · Routledge eBooks · doi:10.1201/9781315140919 · Cited by 15,796
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Self-citationStandards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Cox, D. R., & Oakes, D. (2018) · Chapman & Hall/CRC eBooks · doi:10.1201/9781315137438 · Cited by 6,234
Density Estimation for Statistics and Data Analysis
Dehnad, K. (1987) · Technometrics · doi:10.1080/00401706.1987.10488295 · Cited by 5,302
Fitzmaurice, G. M., Laird, N. M., & Ware, J. H. (2011) · Wiley Series in Probability and Statistics · doi:10.1002/9781119513469 · Cited by 4,639
Breslow, N., Cox, D. R., & Oakes, D. (1985) · Biometrics · doi:10.2307/2530888 · Cited by 4,333
Standards of Medical Care in Diabetes—2009
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s013 · Cited by 2,167
(2004) · Choice Reviews Online · doi:10.5860/choice.42-2265 · Cited by 1,384
Risk Factors for Renal Dysfunction in Type 2 Diabetes
Retnakaran, R., Cull, C. A., Thorne, K. I., Adler, A. I., Holman, R. R., & for the UKPDS Study Group (2006) · Diabetes · doi:10.2337/db05-1620 · Cited by 927
Self-citation
Cited by
Items 101–200 of 310
Direct Diabetes-Related Costs in Young Patients with Early-Onset, Long-Lasting Type 1 Diabetes
Bächle, C., Icks, A., Straßburger, K., Flechtner‐Mors, M., Hungele, A., Beyer, P., Placzek, K., Hermann, U., Schumacher, A., Freff, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070567 · Cited by 40
Dorhofer, L., Lammert, A., Krane, V., Gorski, M., Banas, B., Wanner, C., Krämer, B. K., Heid, I. M., Böger, C. A., & for the DIACORE Study Group (2013) · BMC Medical Genetics · doi:10.1186/1471-2350-14-25 · Cited by 41
Self-citationChowdhury, N. H., Reaz, M. B. I., Haque, F., Ahmad, S., Ali, S. H. M., Bakar, A. A. A., & Bhuiyan, M. A. S. (2021) · Diagnostics · doi:10.3390/diagnostics11122267 · Cited by 39
Salardi, S., Balsamo, C., Zucchini, S., Maltoni, G., Scipione, M., Rollo, A., Gualandi, S. C., & Cicognani, A. (2011) · Diabetes Care · doi:10.2337/dc10-1177 · Cited by 36
Progression of Diabetic Kidney Disease in the Absence of Albuminuria
MacIsaac, R. J., & Ekinci, E. I. (2019) · Diabetes Care · doi:10.2337/dci19-0030 · Cited by 36
Pugliese, G., Solini, A., Bonora, E., Orsi, E., Zerbini, G., Fondelli, C., Gruden, G., Cavalot, F. L., Lamacchia, O., Trevisan, R., et al. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-59 · Cited by 38
Self-citationDiabetic kidney disease: Is there a non-albuminuric phenotype in type 2 diabetic patients?
Laranjinha, I., Matias, P., Mateus, S., Aguiar, F. L., Pereira, P., Santos, M. P., Costa, R., Lourenço, A., Guia, J., Barata, J. D., et al. (2016) · Nefrología · doi:10.1016/j.nefro.2016.03.025 · Cited by 44
Nonproteinuric progressive diabetic kidney disease
Zoccali, C., & Mallamaci, F. (2019) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000489 · Cited by 39
Novel Urinary Biomarkers in Early Diabetic Kidney Disease
Kamijo‐Ikemori, A., Sugaya, T., & Kimura, K. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0513-1 · Cited by 36
McKay, G. J., Paterson, E., Maxwell, A. P., Cardwell, C. R., Wang, R., Hogg, S., MacGillivray, T., Trucco, E., & Doney, A. S. F. (2018) · Scientific Reports · doi:10.1038/s41598-018-22360-3 · Cited by 34
Wang, J., Li, H., Tan, M., Gao, G., Zhang, Y., Ding, B., Su, X., Kong, X., & Ma, J. (2019) · Oncotarget · doi:10.18632/oncotarget.26265 · Cited by 41
FcER1: A Novel Molecule Implicated in the Progression of Human Diabetic Kidney Disease
Sur, S., Nguyen, M., Boada, P., Sigdel, T. K., Sollinger, H. W., & Sarwal, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.769972 · Cited by 34
Yamamoto, Y., Hanai, K., Mori, T., Yokoyama, Y., Yoshida, N., Murata, H., Shinozaki, T., & Babazono, T. (2021) · Diabetologia · doi:10.1007/s00125-021-05590-5 · Cited by 33
Spectrum of renal disease in diabetes
Teng, J. H., Dwyer, K. M., Hill, P., See, E. J., Ekinci, E. I., Jerums, G., & MacIsaac, R. J. (2014) · Nephrology · doi:10.1111/nep.12288 · Cited by 38
Diabetic retinopathy and renal function in Chinese type 2 diabetic patients
Zhang, H., Wang, J., Ying, G., Shen, L., & Zhang, Z. (2014) · International Urology and Nephrology · doi:10.1007/s11255-014-0675-4 · Cited by 31
Type 2 diabetes mellitus management in patients with chronic kidney disease: an update
Kleinaki, Z., Kapnisi, S., Theodorelou‐Charitou, S., Nikas, I. P., & Paschou, S. Α. (2020) · HORMONES · doi:10.1007/s42000-020-00212-y · Cited by 32
Serum Cystatin C Trajectory Is a Marker Associated With Diabetic Kidney Disease
Wang, N., Lu, Z., Zhang, W., Bai, Y., Pei, D., & Li, L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.824279 · Cited by 30
Renal function deterioration in adult patients with type-2 diabetes
Bramlage, P., Lanzinger, S., Hess, E., Fahrner, S., Heyer, C. H. J., Friebe, M., Buschmann, I. R., Danne, T., Holl, R. W., & Seufert, J. (2020) · BMC Nephrology · doi:10.1186/s12882-020-01952-0 · Cited by 30
Chida, S., Fujita, Y., Ogawa, A., Hayashi, A., Ichikawa, R., Kamata, Y., Takeuchi, A., Takano, K., & Shichiri, M. (2016) · Scientific Reports · doi:10.1038/srep26380 · Cited by 29
Neutrophil count as a reliable marker for diabetic kidney disease in autoimmune diabetes
Yu, Y., Lin, Q., Ye, D., Wang, Y., He, B., Li, Y., Huang, G., Zhou, Z., & Xiao, Y. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-00597-2 · Cited by 30
CTLA4-Ig in B7-1-positive diabetic and non-diabetic kidney disease
Bassi, R., Fornoni, A., Doria, A., & Fiorina, P. (2015) · Diabetologia · doi:10.1007/s00125-015-3766-6 · Cited by 27
Adeva‐Andany, M. M., Fernández‐Fernández, C., Funcasta-Calderón, R., Ameneiros-Rodríguez, E., Adeva-Contreras, L., & Castro-Quintela, E. (2021) · Current Diabetes Reviews · doi:10.2174/1573399818666211117122604 · Cited by 29
Diabetic kidney disease in children and adolescents: an update
Lopez, L. N., Wang, W., Loomba, L. A., Afkarian, M., & Butani, L. (2021) · Pediatric Nephrology · doi:10.1007/s00467-021-05347-7 · Cited by 31
Vítová, L., Tůma, Z., Moravec, J., Kvapil, M., Matějovič, M., & Mareš, J. (2017) · BMC Nephrology · doi:10.1186/s12882-017-0519-4 · Cited by 27
Xue, P., Covassin, N., Ran, X., Zhou, J., Zhang, X., Yan, D., Li, X., Gao, Y., & Tang, X. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108484 · Cited by 27
Association Analysis of Dyslipidemia-Related Genes in Diabetic Nephropathy
McKay, G. J., Savage, D. A., Patterson, C., Lewis, G. A., McKnight, A. J., Maxwell, A. P., & the Warren 3/UK GoKinD Study Group (2013) · PLoS ONE · doi:10.1371/journal.pone.0058472 · Cited by 27
Cardiovascular complications of type 1 diabetes: update on the renal link
Orchard, T. J., & Costacou, T. (2016) · Acta Diabetologica · doi:10.1007/s00592-016-0949-7 · Cited by 29
Sakamoto, F., Katakami, N., Kaneto, H., Yasuda, T., Takahara, M., Miyashita, K., Kuroda, A., Matsuhisa, M., Kosugi, K., & Shimomura, I. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej12-0238 · Cited by 25
Re-understanding and focusing on normoalbuminuric diabetic kidney disease
An, N., Wu, B., Yang, Y., Huang, Z.-H., & Feng, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1077929 · Cited by 27
Attenuated kidney oxidative metabolism in young adults with type 1 diabetes
Choi, Y. J., Richard, G. M., Zhang, G., Hodgin, J. B., Demeke, D., Yang, Y., Schaub, J. A., Tamayo, I. M., Gurung, B. K., Naik, A. S., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci183984 · Cited by 24
Multifaceted relationship between diabetes and kidney diseases: Beyond diabetes
Esposito, P. B., Picciotto, D., Cappadona, F., Costigliolo, F., Russo, E., Macciò, L., & Viazzi, F. C. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i10.1450 · Cited by 26
Uruska, A. A., Araszkiewicz, A., Uruski, P., & Zozulińska‐Ziółkiewicz, D. (2014) · Microvascular Research · doi:10.1016/j.mvr.2014.01.002 · Cited by 26
Dadlani, V., Kaur, R. J., Stegall, M. D., Xyda, S., Kumari, K., Bonner, K., Smith, B. H., Thapa, P. B., Dean, P. G., & Kudva, Y. C. (2019) · Clinical Transplantation · doi:10.1111/ctr.13719 · Cited by 24
Zheng, T., Liu, Y., Qin, S., Liu, H., Zhang, X., & Zhao, H. (2016) · Diabetes and Vascular Disease Research · doi:10.1177/1479164115615356 · Cited by 23
Defining, Treating, and Understanding Chronic Kidney Disease—A Complex Disorder
Campbell, D., & Weir, M. R. (2015) · Journal of Clinical Hypertension · doi:10.1111/jch.12560 · Cited by 24
Does Altered Uric Acid Metabolism Contribute to Diabetic Kidney Disease Pathophysiology?
Gul, A., & Zager, P. G. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-0985-5 · Cited by 22
Zhou, L., Lv, L., Qiu, S., Yin, Q., Li, Z., Tang, T., Ni, L., Ye, F., Wang, B., Ma, K., et al. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1818-2 · Cited by 21
Chapter 4: Blood pressure management in CKD ND patients with diabetes mellitus
(2012) · Kidney International Supplements · doi:10.1038/kisup.2012.54 · Cited by 23
Saha, T. K., Bhattarai, A. M., Batra, H. S., Banerjee, M., Misra, P., & Ambade, V. N. (2014) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-014-0439-z · Cited by 20
(AdDIT), T. A. T. 1. D. C.-R. I. T., Benitez‐Aguirre, P., Wong, T. Y., Craig, M. E., Davis, E. A., Cotterill, A. M., Couper, J., Cameron, F. J., Mahmud, F. H., Jones, T. W., et al. (2018) · Diabetologia · doi:10.1007/s00125-017-4538-2 · Cited by 20
Normoalbuminuric kidney impairment in patients with T1DM: insights from annals initiative
Lamacchia, O., Viazzi, F. C., Fioretto, P., Mirijello, A., Giorda, C. B., Ceriello, A., Russo, G. T., Guida, P., Pontremoli, R., & Cosmo, S. D. (2018) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-018-0361-2 · Cited by 21
Clinical and Pathological Characteristics of Patients With Nonproteinuric Diabetic Nephropathy
Chang, D., Li, M., Yu, X., Wang, S., Chen, M., & Zhao, M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.761386 · Cited by 23
Update on pathogenesis and diagnosis flow of normoalbuminuric diabetes with renal insufficiency
Deng, L., Li, W., & Xu, G. (2021) · European journal of medical research · doi:10.1186/s40001-021-00612-9 · Cited by 22
Diabetes mellitus type 1 in adults
Dedov, I. I., Shestakova, M. V., Mayorov, A. Y., Шамхалова, М. Ш., Nikonova, T. V., Sukhareva, O. Y., Пекарева, Е. В., Ibragimova, L. I., Mikhina, M. S., Galstyan, G. R., et al. (2020) · Diabetes Mellitus · doi:10.14341/dm12505 · Cited by 22
Guo, M., Niu, J., Ye, X., Han, X., Zha, Y., Hong, Y., Fang, H., & Gu, Y. (2017) · Clinical Interventions in Aging · doi:10.2147/cia.s140289 · Cited by 21
Garofolo, M., Russo, E., Miccoli, R., Lucchesi, D., Giusti, L., Sancho‐Bornez, V., Daniele, G., Prato, S. D., & Penno, G. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.03.012 · Cited by 20
Paccosi, S., Musilli, C., Mangano, G., Guglielmotti, A., & Parenti, A. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.09.006 · Cited by 18
Non-Albumin Proteinuria (NAP) as a Complementary Marker for Diabetic Kidney Disease (DKD)
Bae, J., Won, Y. J., & Lee, B. (2021) · Life · doi:10.3390/life11030224 · Cited by 18
Advancements in nanomedicines for the detection and treatment of diabetic kidney disease
Tillman, L., Tabish, T. A., Kamaly, N., Moss, P., El-briri, A., Thiemermann, C., Pranjol, M. Z. I., & Yaqoob, M. M. (2022) · Biomaterials and Biosystems · doi:10.1016/j.bbiosy.2022.100047 · Cited by 19
Novel biomarkers for diabetic kidney disease
Jung, C., & Yoo, T. (2022) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.22.084 · Cited by 17
Zhong, M., Shen, W., Tabuchi, M., Nakamura, K., Chen, Y., Qiao, C., He, J., Yang, J., Zhang, C., Kamenov, Z. A., et al. (2011) · Experimental Diabetes Research · doi:10.1155/2012/429020 · Cited by 16
Update on Blood Pressure Control and Renal Outcomes in Diabetes Mellitus
Joven, M. H., & Anderson, R. J. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0613-6 · Cited by 18
Ivory, S. E., Packham, D., Reutens, A. T., Wolfe, R. S., Rohde, R. D., Lewis, J. B., Atkins, R. C., & the Collaborative Study Group (2013) · Nephrology · doi:10.1111/nep.12053 · Cited by 16
Wal, P., Tyagi, S., Pal, R. S., Yadav, A., & Jaiswal, R. (2022) · Current Diabetes Reviews · doi:10.2174/1573399818666220426091238 · Cited by 16
Sigfrids, F. J., Lithovius, R., Groop, P., & Thorn, L. M. (2024) · Diabetic Medicine · doi:10.1111/dme.15431 · Cited by 16
The Familiality of Rapid Renal Decline in Diabetes
Frodsham, S. G., Yu, Z., Lyons, A., Agarwal, A., Pezzolesi, M. H., Li, D., Srinivas, T. R., Ying, J., Greene, T., Raphael, K. L., et al. (2018) · Diabetes · doi:10.2337/db18-0838 · Cited by 14
Hueros, J. I. C., Hidalgo-Barquero, M. V. M., Morales-Gabardino, J. A., & Buitrago, F. (2020) · Primary care diabetes · doi:10.1016/j.pcd.2020.11.015 · Cited by 16
Singh, S. K., Patel, P. S., & Singh, A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12051778 · Cited by 14
Zhong, M., Shen, W., Wang, J., Yang, J., Yuan, W., He, J., Wu, P., Wang, Y., Zhang, L., Higashino, H., et al. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2011.213686 · Cited by 14
Mottl, A. K., Lauer, A., Dabelea, D., Maahs, D. M., Agostino, R. B. D., Dolan, L. M., Gilliam, L. K., Lawrence, J. M., Rodríguez, B. L., Marcovina, S. M., et al. (2013) · Diabetes Care · doi:10.2337/dc13-0568 · Cited by 13
Self-citationBjornstad, P., Costacou, T., Miller, R. G., Maahs, D. M., Rewers, M., Orchard, T. J., & Snell‐Bergeon, J. K. (2017) · Diabetic Medicine · doi:10.1111/dme.13430 · Cited by 14
Assessment of estimated glomerular filtration rate based on cystatin C in diabetic nephropathy
Akpınar, K., Aslan, D., & Fenkçi, S. M. (2021) · Brazilian Journal of Nephrology · doi:10.1590/2175-8239-jbn-2020-0145 · Cited by 13
Bonito, P. D., Mozzillo, E., Rosanio, F. M., Maltoni, G., Piona, C. A., Franceschi, R., Ripoli, C., Ricciardi, M. R., Tornese, G., Arnaldi, C., et al. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.03.019 · Cited by 14
Bell, D. S. H. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01168-x · Cited by 12
Menini, S., Iacobini, C., Pugliese, G., & Pesce, C. M. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2016.1278355 · Cited by 13
Jenkins, A. J., Yu, Y., Alaupovic, P., Basu, A., Klein, R. L., Lopes-Virella, M. F., Baker, N. L., Hunt, K. J., Lackland, D. T., Garvey, W. T., et al. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.06.002 · Cited by 12
Hyvönen, M. E., Dumont, V., Tienari, J., Lehtonen, E., Ustinov, J., Havana, M., Jalanko, H., Otonkoski, T., Miettinen, P. J., & Lehtonen, S. H. (2015) · BioMed Research International · doi:10.1155/2015/102969 · Cited by 12
Normoalbuminuric chronic kidney disease in diabetes
Klimontov, V. V., & Korbut, A. I. (2018) · Terapevticheskii arkhiv · doi:10.26442/terarkh201890104-98 · Cited by 12
Aqeel, S. B., Ye, M., Wysocki, J. A., Sánchez-Nadales, A., Khattab, A., Lores, E., RADEMAKER, A. W., Gao, X., Bebu, I., Nelson, R. G., et al. (2019) · Physiological Reports · doi:10.14814/phy2.14242 · Cited by 11
Self-citationProgression and regression of kidney disease in type 1 diabetes
Sigfrids, F. J., & Groop, P. (2023) · Frontiers in Nephrology · doi:10.3389/fneph.2023.1282818 · Cited by 12
Integrated multiomic analyses: An approach to improve understanding of diabetic kidney disease
Hill, C., McKnight, A. J., & Smyth, L. J. (2024) · Diabetic Medicine · doi:10.1111/dme.15447 · Cited by 11
Altaf, Q. A., Sadiqi, H., Piya, M. K., & Tahrani, A. A. (2016) · BMC Endocrine Disorders · doi:10.1186/s12902-016-0147-1 · Cited by 11
Gawryś, J., Gawryś, K., Szahidewicz-Krupska, E., Derkacz, A., Mochol, J., & Doroszko, A. (2018) · BioMed Research International · doi:10.1155/2018/7902081 · Cited by 11
Non-albuminuric reduced eGFR phenotype in children and adolescents with type 1 diabetes
Bonito, P. D., Mozzillo, E., Esposito, M., Rosanio, F. M., Casertano, A., Fattorusso, V., & Franzese, A. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.07.005 · Cited by 11
Lee, J.-H., Yang, F., Tsai, W., Lee, C.-T., Liu, S., Yang, W., & Tung, Y. (2021) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2021.06.022 · Cited by 11
Makvandi, K., Eliasson, B., Carlsen, H. K., & Baid‐Agrawal, S. (2024) · Diabetes Care · doi:10.2337/dc24-0908 · Cited by 11
Early Glomerular Filtration Rate Loss as a Marker of Diabetic Nephropathy
Jerums, G., Ekinci, E. I., Panagiotopoulos, S., & MacIsaac, R. J. (2012) · US Endocrinology · doi:10.17925/use.2012.08.01.40 · Cited by 11
Kidney biopsy can help to predict renal outcomes of patients with type 2 diabetes mellitus
Kim, W.-J., Oh, T., Heo, N. H., Kwon, K., Shin, G.-E., Jeong, S.-H., Lee, J., Park, S., Cho, N., Gil, H., et al. (2024) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.23.059 · Cited by 10
Petzuch, B., Benardeau, A. M., Hofmeister, L. H., Meyer, J., Hartmann, E., Pavkovic, M., Mathar, I., Sandner, P., & Ellinger-Ziegelbauer, H. C. (2022) · Toxicological Sciences · doi:10.1093/toxsci/kfac028 · Cited by 10
Chowdhury, N. H., Reaz, M. B. I., Ali, S. H. M., Ahmad, S., Crespo, M. L., Cicuttin, A., Haque, F., Bakar, A. A. A., & Bhuiyan, M. A. S. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12091507 · Cited by 10
Can Improved Glycemic Control Slow Renal Function Decline at All Stages of Diabetic Nephropathy?
Goel, G., & Perkins, B. A. (2012) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2012.07.004 · Cited by 12
Complicações crônicas do diabetes
Tschiedel, B. (2014) · J. bras. med · Cited by 10
Uçaktürk, S. A., Mengen, E., Elmaoğulları, S., Yücel, Ç., Yılmaz, A. A., & Çifci, A. (2019) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2018-0373 · Cited by 10
Intensive Diabetes Therapy and Glomerular Filtration Rate in Type 1 Diabetes
Garrick, R. (2012) · Yearbook of Medicine · doi:10.1016/j.ymed.2012.08.051 · Cited by 10
Perkins, B. A., Bebu, I., Gao, X., Karger, A. B., Hirsch, I. B., Karanchi, H., Molitch, M. E., Zinman, B., Lachin, J. M., & de Boer, I. H. (2022) · Diabetes Care · doi:10.2337/dc21-1883 · Cited by 9
Self-citationLee, E., Oh, H. J., Park, J. T., Han, S. H., Ryu, D., Kang, S., & Yoo, T. (2016) · Medicine · doi:10.1097/md.0000000000003175 · Cited by 11
Sämann, A., & Wolf, G. (2012) · Der Internist · doi:10.1007/s00108-012-3129-z · Cited by 9
Fabre, L., Pedregosa-Miguel, J. F., & Rangel, É. B. (2024) · Diabetology · doi:10.3390/diabetology5040030 · Cited by 8
Secrest, A. M., Washington, R., & Orchard, T. J. (2018) · Europe PMC (PubMed Central) · Cited by 20
Clinical profile of nonproteinuric kidney disease in type 2 diabetic patients in India
Yadav, R. K., Sangha, S. S., Subbiah, A., Bagchi, S., Mahajan, S., Bhowmik, D. M., & Agarwal, S. (2023) · Indian Journal of Nephrology · doi:10.4103/ijn.ijn_54_22 · Cited by 7
Kim, H. J., Kim, S. S., & Song, S. H. (2022) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2021.515 · Cited by 8
Ho, K., & McKnight, A. J. (2014) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2014.03.002 · Cited by 7
Aslanhan, E., Ojalvo, D., Özşenel, E. B., Basat, S., & Borlu, F. (2019) · Cardiovascular Endocrinology & Metabolism · doi:10.1097/xce.0000000000000180 · Cited by 7
Urinary Alpha- and Pi-Glutathione S-Transferases in Adult Patients with Type 1 Diabetes
von Scholten, B. J., Theilade, S., Lajer, M., & Rossing, P. R. (2014) · Nephron Extra · doi:10.1159/000365481 · Cited by 7
Wang, Z., Wang, F., Liu, C., & Zhang, L. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-077338 · Cited by 6
Non-Proteinuric Diabetic Kidney Disease: A Comprehensive Review
Natarajan, P., Shaik, F., Chatterjee, A., & Prabhakar, S. S. (2026) · Life · doi:10.3390/life16040533 · Cited by 5
A Transcriptional Blueprint for Human and Murine Diabetic Kidney Disease
Bhalla, V., Velez, M.-G., & Chertow, G. M. (2012) · Diabetes · doi:10.2337/db12-1121 · Cited by 5
Altıncık, A., Yıldırımçakar, D., Avcı, E., Özhan, B., Girişgen, İ., & Yüksel, S. (2023) · Pediatric Nephrology · doi:10.1007/s00467-023-06019-4 · Cited by 5
Urinary adiponectin and progression of diabetic nephropathy in type 1 diabetes
Ha, K. H., & Kim, D. J. (2015) · Journal of Diabetes Investigation · doi:10.1111/jdi.12427 · Cited by 5
The Juvenile Diabetes Research Foundation at Forty: Updates of Research in Type 1 Diabetes
Nierras, C. R., Atkinson, M. A., & Goldstein, R. A. (2010) · Diabetes · doi:10.2337/db10-0622 · Cited by 7
Metadata
- Authors
- Molitch, M. E., Steffes, M., Sun, W., Rutledge, B., Cleary, P., de Boer, I. H., Zinman, B., Lachin, J., & for the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Group
- Affiliations
- Northwestern University (US)
- University of Minnesota (US)
- George Washington University (US)
- Weststat, Rockville, Maryland;
- University of Washington, Seattle, Washington;
- University of Toronto (CA)
- Corresponding author
- Cleary, Patricia
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-04-22
- Volume
- 33
- Issue
- 7
- Pages
- 1536-1543
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2890355
- OpenAlex
- W2112283107
- Semantic Scholar
- 28dfcf1a74005b6164f159cf1b64cfec2aecc582
- Cited by
- 306
- References
- 31
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 15 · 2023: 13 · 2022: 25 · 2021: 19 · 2020: 17 · 2019: 25 · 2018: 23 · 2017: 17 · 2016: 17 · 2015: 24 · 2014: 33 · 2013: 23 · 2012: 22
- FWCI
- 15.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Keywords
- type 1 diabetes, albuminuria, macroalbuminuria, microalbuminuria, urinary albumin excretion rate, chronic kidney disease, estimated glomerular filtration rate decline, renal failure, diabetic nephropathy, Diabetes Control and Complications Trial, kidney disease screening, glycemic control, blood pressure control
- MeSH terms
- Adult, Albuminuria, Creatinine, Diabetes Mellitus, Type 1, Diabetic Nephropathies, Female, Follow-Up Studies, Glomerular Filtration Rate, Humans, Male, Predictive Value of Tests, Risk Factors, Severity of Illness Index, Multicenter Studies as Topic, Incidence, Randomized Controlled Trials as Topic, Disease Progression, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.